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The Human Hepatocirrhosis Virus (HHV) infection of  human hepatocyte cells leads to massive cell death that ultimately causes liver failure, a life threatening 
condition that demands urgent medical care. In the United 
States alone, HHV is responsible for approximately 2,800 
deaths each year and causes irreversible tissue damage that 
affects over 8,200 people that will require lifelong treatment. 
Most often, liver failure occurs gradually over many years 
following HHV infection. The symptoms of  the disease are 
swollen abdomen, mental disorientation, and even coma. 
To prevent infection from the HHV virus one should 
practice proper hygiene and safe sex and avoid consuming 
contaminated food and water. Understanding the functions, 
structure, mechanical processes and characteristics of  HHV 
is crucial for early detection, treatment, and the development 
of  a potential vaccine for the virus. 
Pathology
HHV enters the human body through the mucosa of  the 
mouth, nose, genital area, or open wounds in the skin; however, 
most infections originate from consumption of  contaminated 
food or water. After the virus enters the body, it travels 
through the bloodstream until it reaches the hepatocytes in 
the liver (Figure 1a). Once it encounters the hepatocytes, 
HHV infects cells by binding to a specific receptor unique 
to hepatocytes and starts making copies of  itself. The newly 
assembled viral particles exit the host cell and propagate 
into neighboring hepatocytes, causing massive cell death. 
This activates the immune system, which fight the spread of  
the virus and causes inflammation of  the liver (Figure 1b). 
Since HHV propagates very fast it mutates frequently thus 
preventing the body from building long-lasting immunity 
to the virus. The viral infection and the constant release of  
chemicals by the immune system results in cirrhosis of  the 
liver. Histologically, the HHV damage resembles liver damage 
by Hepatitis viruses, as shown in Figure 1. The liver does not 
have sufficient time to heal itself  thus forming cirrhotic tissue. 
A cirrhotic liver cannot effectively synthesize proteins, filter 
the blood or regulate blood sugar levels. If  left untreated, 
the loss of  liver functions may cause death and other serious 
complications such as cancer. 8
Virion Characteristics 
The Human Hepatocirrhosis Virus is an enveloped virus with 
icosahedral shape (Figure 2a) with an approximate size of  40 to 
60nm. The virus also has the tegument, comprised of  proteins 
that line the space between the envelope and the nucleocapsid 
(Figure 2b). These proteins mainly contribute to viral RNA 
replication, the elimination of  cellular competition and the 
evasion of  the immune response. Dawicasmer12 (DCM12) 
and Rocasmer14 (RC14) are glycoproteins present on the 
surface of  the envelope and play an important role for viral 
attachment and entry to the host cell (Figure 2c).  HHV has 
a negative sense single stranded RNA genome, which is linear 
and nonsegmented. The genome is relatively small (95kB), 
thus the virus has evolved several mechanisms to code as many 
functional proteins as possible as discussed below.
Virus Life Cycle and Interaction with Host Cell
After HHV enters the human body, the virus glycoprotein 
ligands (DCM12 and RC14) will bind to complementarily 
receptors on the surface of  hepatocyte cells named DCM12-C 
and RC14-C. Next, the host cell engulfs the virion via enclosure 
into the cellular membrane forming a vesicle and intaking the 
HHV virus into the cytoplasm of  the cell in a process called 
receptor-mediated endocytosis. Once inside of  the cell, HHV 
will activate its M2 channels that will change the pH of  the 
intracellular environment, disassociating the virion envelope, 
capsid and cellular vesicle. Release of  the HHV RNA genome 
into the cytoplasm will start viral protein synthesis and 
replication using cellular machinery (Figure 3). The replicated 
HHV genome is packaged inside a newly synthesized capsid. 
The virus maturation and release will then follow with new 
HHV virions exiting the host cell via budding. The release 
of  new HHV progeny allows for further infection of  healthy 
cells, repeating the process (Figure 4). 5, 6
HHV Replication and Translation
HHV needs a RNA-dependent RNA-polymerase to replicate 
its negative sense ssRNA genome, an enzyme not found in 
animal cells. The virus codes for its own RNA-dependent 
RNA-polymerase and packages a functional enzyme in each 
virion. To start replication, the viral polymerase complex reads 
the (-)ssRNA genome 3’ to 5’ direction and it synthesizes 
the complementary (+)ssRNA strand 5’ to 3’ direction. The 
same polymerase complex will then read the (+)ssRNA and 
synthesize a new complementary  (-)ssRNA strand (Figure 5a) 
which is then ready to be packaged in a capsid. 6
The virion RNA is negative sense (complementary to mRNA) 
and must therefore be copied into the complementary (+)
ssRNA before viral proteins can be synthesized. (+)ssRNA is 
the same sense as cellular mRNA so it functions as a regular 
mRNA molecule. The newly synthesized viral (+)ssRNA 
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can be translated by cellular ribosomes resulting in protein 
synthesis (Figure 5b). It is critical for HHV to code for RNA-
dependent RNA-polymerase in its genome and also package 
it in the virion capsid so that the polymerase can synthesize 
(+)ssRNAs upon infecting the cell so that translation and 
replication can occur. 6
Evolutionary Gadgets
HHV has a relatively small genome thus it can only code for 
few proteins. To overcome this, HHV has evolved several 
traits that allow it to compensate for its small genome 
and successfully compete with cellular molecules. HHV is 
polycistronic, meaning that a single viral mRNA molecule 
encodes for several different polypeptide chains. When the 
viral mRNA gets translated into proteins, multiple proteins 
are bound together. The viral mRNA is translated into large 
molecules in which multiple proteins are connected together 
into a polyprotein. Enzymes called proteases cleave the huge 
polyprotein resulting into separation of  the individual pieces. 
HHV also encodes for viral de-capping enzymes that degrade 
Effects of  Viral Infection in the Liver 
Figure 1. Histological appearance of  hepatocytes isolated from an individual infected with HHV at different stages of  progression during viral infection. 
A) Micrograph depicts normal/healthy liver tissue before viral infection; (B) inflamed/fibrotic tissue as occurs upon infection; and (C) cirrhotic 
hepatocytes after repetitive exposure to HHV and the activation immune system. 
Virion Characteristics
Figure 2. Model of  the Human Hepatocirrhosis virus.
A virion constructed by using a 4-inch Styrofoam white ball and manually pinning gold and silver thumbstacks in a circular pattern. (A) The envelope of  
the virus is depicted by different thumbstack colors to represent the different proteins found in the envelope of  the virion; (B) is a cross section image 
of  the HHV virus made by cutting a Styrofoam white ball in half  and painting the inside with black marker to represent the viral tegument. A red nylon 
chenille stem was then glued in the middle of  the styrofoam ball which represents the -ssRNA genome of  HHV that is encapsulated by the capsid (not 
depicted); (C) is a HHV model stained with green fluorescent dye (glow stick liquid) to represent the glycoproteins present on the surface of  the virus used 
for identification of  hepatocyte cells.
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the CAP structure of  cellular mRNAs preventing them from 
being translated. This allows HHV mRNAs to be translated 
faster than cellular mRNAs. The virus can also use the CAP 
from the degraded cellular mRNAs and add it to its own 
mRNA molecules. 6 In addition, the viral mRNA has internal 
ribosomal entry site (IRES). This is a unique structure in the 
mRNA molecule of  the virus allowing it to bypass the need 
of  a CAP at the 5’ end of  the mRNA molecule in order for 
translation to occur. Thus, cellular machinery would translate 
the sequence because IRES will mimic the CAP structure. Viral 
polyA polymerase adds a poly-A tail to all viral mRNAs. These 
evolutionary gadgets allow HHV to replicate and synthesize 
proteins efficiently by utilizing cellular machineries. 6
Immune Response and Genomic Changes
Due to a high mutation rate during HHV replication, 
the immune system is relatively inefficient. The lack of  
proofreading activity during viral replication results in genetic 
Figure 3. Schematic of  the mechanism for HHV viral replication and protein 
synthesis. The HHV virus has a (-) ssRNA DNA that is synthesized into 
its complementary (+) ssRNA strand. The (+) ssRNA strand can then be 
translated (protein synthesis) by cellular machinery and replicated (formation 
of  a newly synthesized viral genome). This results in the assembly of  a new 
virus which will exit the host cell and infect new cells.
Figure 4. Schematic of  HHV lytic life cycle and virus/host interaction at the 
cellular level. a) Virus binding (adsorption) and internalization (penetration, 
entry), b) cytoplasmic release and uncoating, c) IRES-mediated translation 
and polyprotein processing that directs the virus to the host endoplasmic 
reticulum, d) RNA replication (biosynthesis), e) packaging and assembly, f) 
virion maturation and release.4 
 
HHV Replication and Translation
Figure 5. Schematic of  HHV replication and translation. HHV has its own transcription and replication factors that allows proper synthesis of  (-)ssRNA 
copies and proteins. (A) The (-)ssRNA from HHV gets synthesized to (+)ssRNA by a polymerase complex. Once it is a (+)ssRNA strand,  the polymerase 
complex can replicate a new (-)ssRNA strand.9 (B) The complementary (+)ssRNA is translated and different proteins are synthesized using cellular 
machinery.1 The diagram in panel A originally appeared in Viralzone/Expasy database9.
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drift, which is the change in the frequency of  a gene variant in 
a population. The majority of  these mutations continuously 
change the structure of  the HHV virus, resulting in an 
activation of  a new immunological response for the same 
virus. Thus, the antibodies that initially recognize and attack 
HHV no longer activate the immune system, therefore the 
immune system has to generate new antibodies, which takes 
time. By then, the virus has already gained new mutations, 
therefore, repeating the cycle. HHV can also inhibit the 
expression of  the major histocompatibility molecule I (MHC 
I), which displays fragments of  viral proteins from within the 
cell to the cell surface so that the immune system can then 
identify and attack the infected cell. Without MHC I the cells 
of  the immune system become practically blind for the virus. 
By inhibiting MHC I, HHV is allotted more time to propagate 
under the radar of  the immune system, thus causing extensive 
damage to the liver. 6 
Currently, there are no vaccines to combat this pathogen, 
however, there are medications that can decrease the propagation 
rate of  the virus to new cells. A hypothetical antiretroviral drug 
called Dawilcasmer prevents HHV infection by binding to the 
hepatocyte receptor (DCM12-C), which unable the virus from 
binding to this glycoprotein and entering the host cell. HHV 
receptor DCM12 has to complimentary bind to a DCM12-C 
receptor in hepatocytes in order to enter the cell. However, 
this interaction gets disrupted by Dawilcasmer that acts as 
antagonist molecule that binds to the DCM12-C receptor, 
preventing the HHV from binding to the DCM12-C receptor 
and entering the cell. 2
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